Keywords: hoechst, builds, neuro, center, hoechst-roussel, pharmaceuticals, pharmaceutical
HOECHST BUILDS US NEURO CENTER
Article | 04 January 1993
Hoechst-Roussel Pharmaceuticals, the US pharmaceutical arm of the German chemical and pharmaceutical company Hoechst, is building a center for molecular ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
